The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant buzz within the British Isles, prompting a notable shift in medication trends. Availability these compounds remains a complex landscape, with public healthcare system provision currently limited and private clinics offering prescriptions at a premium . Worri